Puma Biotechnology Sees FY23 Revenue $205M-$210M Vs $232.31M Est
Portfolio Pulse from Benzinga Newsdesk
Puma Biotechnology has projected its FY23 revenue to be between $205M-$210M, which is lower than the estimated $232.31M.
August 04, 2023 | 2:50 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Puma Biotechnology's lower than expected FY23 revenue forecast could negatively impact its stock price.
Puma Biotechnology's FY23 revenue forecast is lower than the estimated $232.31M, which could disappoint investors and lead to a decrease in the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100